Andreas Kogelnik

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 20:40, January 30, 2020 by Kmdenmark (talk | contribs) (Text replacement - "investinme.eu" to "investinme.org")
Source: www.openmedicinefoundation.org

Andreas ("Andy") M. Kogelnik, MD, PhD, is an internal medicine and infectious diseases specialist and the director of the Open Medicine Institute, Mountain View, California, US.[1] His interests are in bioinformatics and genomic medicine and is committed to the study and treatment of ME/CFS and other chronic illnesses.[1]

Education[edit | edit source]

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Kogelnik is a member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project, sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[2]

Research publications on ME/CFS[edit | edit source]

Articles[edit | edit source]

Talks and interviews[edit | edit source]

The Open Medicine Institute, Part 1,
The Open Medicine Institute, Part 2,
The Open Medicine Institute, Part 3
Interview with Dr. Andreas Kogelnik, Part 1
Interview with Dr. Andreas Kogelnik, Part 2

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 1.4 1.5 "The Clinic". Open Medicine Institute. Retrieved April 17, 2019.
  2. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019. Cite has empty unknown parameter: |dead-url= (help)
  3. Kogelnik, AM; Loomis, K; Hoegh-Petersen, M; Rosso, F; Hischier, C; Montoya, JG. "Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue". Journal of Clinical Virology. 37: Suppl 1:S33-8. doi:10.1016/S1386-6532(06)70009-9. PMID 17276366.
  4. Knox, K.; Carrigan, D.; Simmons, G.; Teque, F.; Zhou, Y.; Hackett, J.; Qiu, X.; Luk, K.-C.; Schochetman, G.; Kogelnik, AM (July 1, 2011). "No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected". Science. 333 (6038): 94–97. doi:10.1126/science.1204963. ISSN 0036-8075.
  5. Montoya, JG; Kogelnik, AM; Bhangoo, M; Lunn, MR; Flamand, L; Merrihew, LE; Watt, T; Kubo, JT; Paik, J; Desai, M (2013), "Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.", Journal of Medical Virology, 85 (12): 2101-9, doi:10.1002/jmv.23713, PMID 23959519
  6. Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
  7. "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
  8. "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
  9. "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.